Literature DB >> 12900810

Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy.

Michael Danielski1, T Alp Ikizler, Ellen McMonagle, Jane Conner Kane, Lara Pupim, Jason Morrow, Jonathan Himmelfarb.   

Abstract

BACKGROUND: Hypoalbuminemia is a powerful predictor of cardiovascular mortality in maintenance hemodialysis patients. Increased biomarkers of acute-phase inflammation and oxidative stress are highly prevalent and also correlate with cardiovascular morbidity and mortality. The extent to which hypoalbuminemia, biomarkers of inflammation, and biomarkers of oxidative stress are linked in this patient population is unknown. We hypothesized that a high proportion of hypoalbuminemic hemodialysis patients also would manifest increased levels of biomarkers of inflammation and oxidative stress.
METHODS: We surveyed 600 maintenance hemodialysis patients and identified 18 severely hypoalbuminemic patients (serum albumin level < 3.2 g/dL [32 g/L]) without recent infection or hospitalization. We then identified 18 age-, race-, sex-, and diabetes-matched normoalbuminemic hemodialysis patients, as well as 18 age-, race-, sex-, and diabetes-matched healthy subjects, for cohort comparison. Measurements of plasma interleukin-6 (IL-6) levels, plasma protein reduced thiol content, plasma protein carbonyl content, and plasma free F2-isoprostane levels, as well as serum concentrations of C-reactive protein (CRP) and prealbumin, were performed for study purposes.
RESULTS: Levels of serum CRP, IL-6, plasma protein thiol oxidation, and protein carbonyl formation were significantly elevated in both hypoalbuminemic and normoalbuminemic hemodialysis patients compared with healthy subjects and also were significantly different in hypoalbuminemic maintenance dialysis patients compared with normoalbuminemic hemodialysis patients. Prealbumin levels were significantly lower in hypoalbuminemic hemodialysis patients than in other groups.
CONCLUSION: There is a high prevalence of inflammation and oxidative stress in the maintenance hemodialysis population. Levels of inflammatory and oxidative stress biomarkers are increased further in hypoalbuminemic compared with normoalbuminemic dialysis patients. Hypoalbuminemia, acute-phase inflammation, and oxidative stress may act synergistically to increase cardiovascular morbidity and mortality risk in maintenance hemodialysis patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12900810     DOI: 10.1016/s0272-6386(03)00653-x

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  42 in total

1.  Decreased number of CD14+TLR4+ monocytes and their impaired cytokine responses to lipopolysaccharide in patients with chronic kidney disease.

Authors:  Zhi Liu; Yan-Hong Kan; Yu-Dan Wei; Xiu-Jiang Li; Fan Yang; Yue Hou; Yu-Jun Du
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-04-16

2.  GST M1 polymorphism associates with DNA oxidative damage and mortality among hemodialysis patients.

Authors:  Yi-Sheng Lin; Szu-Chun Hung; Yau-Huei Wei; Der-Cherng Tarng
Journal:  J Am Soc Nephrol       Date:  2008-12-03       Impact factor: 10.121

3.  Serum Ferritin Variations and Mortality in Incident Hemodialysis Patients.

Authors:  Taehee Kim; Elani Streja; Melissa Soohoo; Connie M Rhee; Rieko Eriguchi; Tae Woo Kim; Tae Ik Chang; Yoshitsugu Obi; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2017-07-14       Impact factor: 3.754

Review 4.  Let them eat during dialysis: an overlooked opportunity to improve outcomes in maintenance hemodialysis patients.

Authors:  Kamyar Kalantar-Zadeh; T Alp Ikizler
Journal:  J Ren Nutr       Date:  2013-01-10       Impact factor: 3.655

5.  The effect of N-acetylcysteine on oxidative serum biomarkers of hemodialysis patients.

Authors:  I Giannikouris
Journal:  Hippokratia       Date:  2015 Apr-Jun       Impact factor: 0.471

6.  Risk Factors for New-Onset Cardiac Valve Calcification in Patients on Maintenance Peritoneal Dialysis.

Authors:  Yunhuan Tian; Sheng Feng; Zhoubing Zhan; Ying Lu; Yancai Wang; Shan Jiang; Kai Song; Huaying Shen
Journal:  Cardiorenal Med       Date:  2016-02-04       Impact factor: 2.041

Review 7.  Diets and enteral supplements for improving outcomes in chronic kidney disease.

Authors:  Kamyar Kalantar-Zadeh; Noël J Cano; Klemens Budde; Charles Chazot; Csaba P Kovesdy; Robert H Mak; Rajnish Mehrotra; Dominic S Raj; Ashwini R Sehgal; Peter Stenvinkel; T Alp Ikizler
Journal:  Nat Rev Nephrol       Date:  2011-05-31       Impact factor: 28.314

8.  Clinical outcomes of peritoneal dialysis patients transferred from hemodialysis: a matched case-control study.

Authors:  Li Zhang; Tao Cao; Zhibin Li; Qiong Wen; Jianxiong Lin; Xiaodan Zhang; Qunying Guo; Xiao Yang; Xueqing Yu; Haiping Mao
Journal:  Perit Dial Int       Date:  2012-11-01       Impact factor: 1.756

Review 9.  Nutritional and anti-inflammatory interventions in chronic heart failure.

Authors:  Kamyar Kalantar-Zadeh; Stefan D Anker; Tamara B Horwich; Gregg C Fonarow
Journal:  Am J Cardiol       Date:  2008-06-02       Impact factor: 2.778

Review 10.  Antiatherogenic effects of vitamin E: the search for the Holy Grail.

Authors:  Dimitrios Kirmizis; Dimitrios Chatzidimitriou
Journal:  Vasc Health Risk Manag       Date:  2009-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.